Investment
Features
FeesSafety
Academy
More
Pluang+

Ryde Group shares plunge over 95% amid lawsuit alleging stock pump-and-dump scheme.

Market News
07 Oct 2026
PRNewsWire
View Source
Bearish
Ryde Group shares plunge over 95% amid lawsuit alleging stock pump-and-dump scheme.

Ryde Group Ltd's stock soared 500% after its March 2024 IPO but then crashed over 95% from its peak by September 2024. Shareholders allege the rally was driven by undisclosed social media promotions, including fake investment clubs and stolen identities, rather than company performance. The lawsuit claims investors were misled by coordinated online hype without proper warnings, leading to massive losses. Investors who bought shares between March and September 2024 may be eligible to join the class action, with a lead plaintiff deadline of November 9, 2026.

Ryde Group Ltd faces a securities class action deadline on November 9, 2026. For readers following the Financials sector, here is Pluang's market snapshot as of Oct 07, 2026 21:02 WIB: out of 85 priced US Financials stocks, 7 rose and 78 fell. HSBC traded at USD 93.43 with a 1-day change of -4.25% and a typical hold time of 36 days, Marathon Digital Holdings Inc (MARA) was at USD 10.51 with -4.19% change and 21 days hold time, and CleanSpark Inc (CLSK) at USD 11.79 with -4.07% change and a 21-day hold time. Pluang order activity showed 65% sell for HSBC, 68% buy for MARA, and 95% buy for CLSK.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
58 minutes ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
1 hour ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
2 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App